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In response to misaligned sister chromatids during mitosis, the spindle checkpoint protein Mad2 inhibits the anaphase-
promoting complex or cyclosome (APC/C) through binding to its mitotic activator Cdc20, thus delaying anaphase
onset. Mad1, an upstream regulator of Mad2, forms a tight core complex with Mad2 and facilitates Mad2 binding to
Cdc20. In the absence of its binding proteins, free Mad2 has two natively folded conformers, termed N1-Mad2/open-
Mad2 (O-Mad2) and N2-Mad2/closed Mad2 (C-Mad2), with C-Mad2 being more active in APC/C
Cdc20 inhibition. Here, we
show that whereas O-Mad2 is monomeric, C-Mad2 forms either symmetric C-Mad2–C-Mad2 (C–C) or asymmetric O-
Mad2–C-Mad2 (O–C) dimers. We also report the crystal structure of the symmetric C–C Mad2 dimer, revealing the basis
for the ability of unliganded C-Mad2, but not O-Mad2 or liganded C-Mad2, to form symmetric dimers. A Mad2 mutant
that predominantly forms the C–C dimer is functional in vitro and in living cells. Finally, the Mad1–Mad2 core complex
facilitates the conversion of O-Mad2 to C-Mad2 in vitro. Collectively, our results establish the existence of a symmetric
Mad2 dimer and provide insights into Mad1-assisted conformational activation of Mad2 in the spindle checkpoint.
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Mad2 dimer. PLoS Biol 6(3): e50. doi:10.1371/journal.pbio.0060050
Introduction
At the metaphase–anaphase transition, a multisubunit
ubiquitin ligase called the anaphase-promoting complex or
cyclosome (APC/C) in complex with its mitosis-speciﬁc
activator Cdc20 mediates the ubiquitination of securin and
cyclin B [1,2]. Degradation of securin and cyclin B activates
separase, which cleaves the Scc1 subunit of cohesin and
triggers sister-chromatid separation [1,2]. Premature sister-
chromatid separation leads to aneuploidy, which contributes
to cancer progression [3,4]. In response to the existence of
sister chromatids that lack attachment of spindle micro-
tubules at their kinetochores, a cell-cycle surveillance system
called the spindle checkpoint inhibits APC/C
Cdc20 through
multiple mechanisms, stabilizes securin and cyclin B, and
delays the onset of anaphase [2,3,5]. The spindle checkpoint
protein Mad2 binds directly to Cdc20 in mitosis and is
essential for checkpoint-dependent inhibition of APC/C [6–
8]. Binding of Mad2 to Cdc20 requires Mad1, an upstream
regulator of Mad2 that binds to Mad2 throughout the cell
cycle [9–11]. Both Mad1 and Cdc20 contain similar short
peptide motifs that mediate Mad2 binding [11]. Either
inactivation or hyperactivation of Mad2 promotes tumori-
genesis in mice [12,13], highlighting the importance of proper
Mad2 regulation in vivo. A series of biochemical, cell
biological, and structural studies has established that Mad2
is a highly unusual two-state protein and that the Mad1-
assisted conformational switch between these two states is
central to Mad2 regulation [5,14].
In an early study, Fang, et al. [8] showed that recombinant
puriﬁed Mad2 has two natively folded conformers, a mono-
mer and a dimer, in the absence of ligand binding or covalent
modiﬁcation. The Mad2 dimer can form tetramers at high
concentrations. The Mad2 dimer, but not the monomer, is
active in APC/C inhibition in Xenopus egg extracts. Further-
more, the Mad2 monomer blocks the function of the Mad2
dimer in a dominant-negative manner. Structural studies
were subsequently carried out to explain this striking two-
state behavior of Mad2. The structures of the Mad2 monomer
and Mad2 in complex with either Mad1 or an unnatural
peptide ligand called Mad2-binding peptide 1 (MBP1) that
mimics the Mad2-binding motifs of Mad1 or Cdc20 were
determined [11,15,16]. These structures revealed that the
Mad2 monomer has a globular domain and a ﬂexible C-
terminal tail. A Mad2 mutant with its C-terminal tail deleted
(Mad2
DC) is an open Mad2 (O-Mad2) monomer, is incapable
of binding to Cdc20, and inhibits the activity of wild-type
Mad2 in a dominant-negative manner. Mad2 undergoes a
dramatic conformational change upon ligand binding. The
peptide ligands are trapped by the C-terminal region of Mad2
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PLoS BIOLOGYin a manner similar to the way that passengers are restrained
by the seat belts in automobiles.
The Mad2 point mutant, Mad2
R133A, has two distinct
monomeric conformers in the absence of ligands, which
allowed us to determine the structure of both natively folded
conformers of Mad2
R133A, termed N1-Mad2/open Mad2
(hereafter referred to as O-Mad2) and N2-Mad2/closed
Mad2 (C-Mad2), by nuclear magnetic resonance (NMR)
spectroscopy [17]. (We initially named these two conformers
N1-Mad2 and N2-Mad2. To avoid confusion, however, we
have decided to adopt the nomenclature of De Antoni et al.
[18].) The structure of unliganded C-Mad2 closely resembles
that of Mad1- or Cdc20-bound C-Mad2 except that the
ligand-binding site is vacant. O-Mad2 can spontaneously
convert to C-Mad2 with slow kinetics (t1/2¼9 h at 30 8C) [17].
Furthermore, cytosolic Mad2 in human cells is an O-Mad2
monomer [17]. Monomeric C-Mad2
R133A, but not O-Ma-
d2
R133A, is active in APC/C
Cdc20 inhibition. In addition, O-
Mad2 and C-Mad2 can form an asymmetric O-Mad2–C-Mad2
(O–C) dimer that is less active in APC/C
Cdc20 inhibition [17],
explaining why Mad2
DC (which only adopts the O-Mad2
conformation) can block the activity of wild-type Mad2 in a
dominant-negative manner. Finally, Mad1 facilitates the
conversion of O-Mad2 to C-Mad2 in vitro [17]. Mad2 is
targeted to unattached kinetochores by Mad1 and turns over
rapidly at the kinetochores as revealed by ﬂuorescence
recovery after photobleaching (FRAP) studies [9,19–21].
These studies suggest that Mad1 activates Mad2 at kineto-
chores by facilitating the structural conversion of O-Mad2 to
C-Mad2.
More recent FRAP studies revealed that only about 50% of
kinetochore-bound Mad2 undergoes fast exchange with its
cytosolic pool [22], suggesting that there is a stably bound
pool of Mad2 at the kinetochores. Musacchio and coworkers
then showed that this stably kinetochore-bound pool of Mad2
forms a tight complex with Mad1 and adopts the C-Mad2
conformation [16,18]. The Mad1–Mad2 core complex recruits
cytosolic O-Mad2 to kinetochores through asymmetric O–C
Mad2 dimerization.
All available data thus support the following main frame-
work to explain the mechanism by which Mad1 assists the
binding of Mad2 to Cdc20 (Figure 1) [14,17,18,23–26]. In this
model, Mad2 has two distinct conformations of roughly equal
free energy: a latent O-Mad2 and an active C-Mad2. The
Mad1–Mad2 core complex recruits another copy of cytosolic
O-Mad2 to kinetochore through O–C Mad2 dimerization. O-
Mad2 bound to the Mad1–Mad2 core complex undergoes a
conformational change to adopt a short-lived, high-energy
intermediate conformation (I-Mad2). (I-Mad2 was previously
referred to as O*-Mad2. To avoid confusion, we will use the
uniﬁed nomenclature described in [24,25].) I-Mad2 can be
directly passed onto Cdc20 from the Mad1–Mad2 core
complex. Alternatively, at least a fraction of I-Mad2 converts
to unliganded C-Mad2, which dissociates from Mad1. Because
Mad1 is a homodimer, two C-Mad2 molecules dissociated
from Mad1 are expected to form a symmetric C-Mad2–C-
Mad2 (C–C) Mad2 dimer. These unliganded C-Mad2 species
are more active for Cdc20 binding and APC/C inhibition.
Chemical shift perturbation experiments had initially sug-
gested that, upon binding to C-Mad2, O-Mad2 undergoes a
large conformational change to become I-Mad2 [23]. The
structure of the asymmetric O-Mad2–C-Mad2 dimer has,
however, revealed that O-Mad2 bound to C-Mad2 has
virtually the same conformation as does free O-Mad2 [25].
Figure 1. Model for Mad1-Assisted Mad2 Activation during Checkpoint Signaling
(A) A model for the conformational activation of Mad2. The symbols used for different Mad2 conformers are shown in the yellow box. The Mad2-
binding motif of Mad1 is colored red.
(B) Energy diagram for the Mad2 conversion. In the absence of Mad1 or Cdc20, purified O-Mad2 spontaneously converts into unliganded C-Mad2,
because O-Mad2 is at a slightly higher energy state relative to unliganded C-Mad2. We postulate that the O–C Mad2 conversion proceeds via an
undefined intermediate state of Mad2, termed I-Mad2. The energetic barrier between C-Mad2 and I-Mad2 may be lower than that between O-Mad2 and
I-Mad2. Thus, C-Mad2 can reach the I-Mad2 conformation more easily than O-Mad2, explaining why C-Mad2 is more active in APC/C
Cdc20 inhibition. The
Mad1–Mad2 core complex facilitates the O–C Mad2 conversion by lowering the energetic barrier between O-Mad2 and I-Mad2.
doi:10.1371/journal.pbio.0060050.g001
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Structure of the Symmetric Mad2 Dimer
Author Summary
Chromosome missegregation during mitosis results in the gain or
loss of chromosomes in the next generation of cells and can
contribute to birth defects or cancer. A cellular surveillance system
called the spindle checkpoint ensures that accurate chromosome
segregation occurs by inhibiting the activity of the anaphase-
promoting complex or cyclosome (APC/C) until all sister chromatids
have achieved proper attachment to the mitotic spindle. The spindle
checkpoint protein Mad2 binds to Cdc20, an activator of APC/C, and
inhibits the complex. The Mad2 protein can adopt either an open or
closed conformation. The conformational switch in Mad2 is critical
for Cdc20 binding and APC/C inhibition, and is regulated by the
protein Mad1. We report the crystal structure of the symmetric
Mad2 dimer, which is made up of two closed monomers, and is
active in APC/C-Cdc20 inhibition. Mad1 seems to facilitate the open–
closed conformational switch of Mad2, and we present a unified
model to explain Mad1-assisted Mad2 activation in the spindle
checkpoint.Thus, I-Mad2 is not the stable conformation of O-Mad2
bound to C-Mad2, but rather a high-energy state with a ﬁnite
lifetime. The existence and nature of I-Mad2 remain to be
established.
In this study, we performed systematic mutagenesis studies
of human Mad2 and obtained Mad2 mutants that preferably
adopt the closed conformation. We determined the crystal
structure of one such mutant, Mad2
L13A, demonstrating
unequivocally that C-Mad2 can form a symmetric C–C dimer
in vitro. Using NMR spectroscopy, we showed that the wild-
type Mad2 can form both an asymmetric O–C dimer and a
symmetric C–C dimer. Mad2
L13A, which predominantly exists
as the symmetric C–C Mad2 dimer, is functional in cells and is
active in APC/C
Cdc20 inhibition in vitro. Finally, the Mad1–
Mad2 core complex enhances the conversion of O-Mad2 to C-
Mad2. These ﬁndings provide further mechanistic insights
into the conformational activation of Mad2 by Mad1 in the
spindle checkpoint.
Results/Discussion
Identification of Conformation-Specific Mad2 Mutants
We have previously shown that Mad2
R133A forms mono-
meric O-Mad2 and C-Mad2 conformers that interconvert
with slow kinetics [17]. The monomeric open and closed
conformers of Mad2
R133A can be separated by anion
exchange chromatography at 4 8C. O-Mad2 elutes at 150
mM salt, whereas C-Mad2 elutes at 260 mM salt. Inspection of
their surface electrostatic potentials reveals that C-Mad2
contains a contiguous, negatively charged patch centered
around b6 that is absent in O-Mad2 because b6 is largely
buried by b7 and b8 (Figure S1). The presence of this
negatively charged patch provides a possible explanation for
the tighter association of C-Mad2 with the positively charged
resin of the anion exchange column.
We performed systematic structure-based mutagenesis to
identify Mad2 mutants that preferably adopt either the open
or closed conformation in the background of the R133A
mutation. We used the elution proﬁles of anion exchange
chromatography and NMR spectroscopy to determine the
conformational state of the Mad2 mutants and to measure of
the O–C conversion rates of mutants that can form both
conformers. The binding afﬁnities of these Mad2 mutants
toward the Mad2-binding motif of Cdc20 were determined by
isothermal titration calorimetry (ITC). The results from these
studies are summarized in Table 1. Previous studies showed
that a Mad2 mutant with its C-terminal ten residues deleted
(Mad2
DC) exclusively adopts the open conformation and can
no longer interact with Cdc20 [8,15,17]. The majority of Mad2
mutants formed both O-Mad2 and C-Mad2 conformers that
interconverted with rates similar to that of Mad2
R133A.
However, several Mad2 mutants behaved similarly to Mad2
DC
and only adopted the open conformation, including F186A,
T188A, H191A, V197A, and Y199A (Figure 2). None of these
Table 1. Summary of the Properties of Mad2 Mutants
Class
a Mad2 Mutants Conformation Conversion Rates (10
 5 s
 1)
b Cdc20 Binding (Kd, lM)
c
I R133A O, C 5.0 0.14
R133A, T12A O, C 22 0.11
R133A, L84A O, C 12 0.16
R133A, I88A O, C 1.7 0.20
R133A, F151A O, C 1.0 0.29
R133A, L154A O, C 4.2 1.21
R133A, D158A O, C 5.0 0.13
R133A, D160A O, C 10 0.26
R133A, V163A O, C 6.5 0.23
R133A, P164A O, C 8.8 ND
R133A, S170A O, C 4.8 0.081
R133A, E179A O, C 5.0 0.16
R133A, V181A O, C 3.8 0.10
R133A, T187A O, C 27 ND
R133A, K192A O, C ND ND
R133A, K200A O, C 2.8 0.17
II R133A, W167A O, C 20 NBD
III R133A, L13A C N/A 0.12
R133A, L153A C N/A 0.21
R133A, Y156A C N/A 0.56
IV R133A, W75A C N/A NBD
V R133A, F186A O N/A NBD
R133A, T188A O N/A NBD
R133A, H191A O N/A NBD
R133A, V197A O N/A NBD
R133A, Y199A O N/A NBD
aMutant classes: I, mutants that are capable of adopting both open (O) and closed (C) conformations and are able to bind to Cdc20; II, mutants that are capable of adopting both
conformations but are unable to bind to Cdc20; III, mutants that predominantly adopt the C-conformation and are able to bind to Cdc20; IV, mutants that predominantly adopt the C
conformation but are unable to bind to Cdc20; V, mutants that predominantly adopt the O-conformation but are unable to bind to Cdc20.
bAll rate constants were measured by NMR at 30 8C.
cKd is measured for the binding of the C-conformer of each mutant to a synthetic peptide containing residues 124–141 of human Cdc20 by isothermal titration calorimetry (ITC).
N/A, not applicable; NBD, no binding detected; ND, not determined.
doi:10.1371/journal.pbio.0060050.t001
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Structure of the Symmetric Mad2 Dimermutants had detectable binding toward Cdc20 (Table 1). In
addition, we identiﬁed several Mad2 mutations that selec-
tively destabilized the open conformation of Mad2, such as
L13A, W75A, L153A, and Y156A. These mutants preferably
adopted the closed conformation (Figure 2). Among these C-
Mad2-speciﬁc mutants, Mad2
L13A, Mad2
L153A, and Mad2
Y156A
retained their ability to bind to Cdc20 (Table 1), consistent
with C-Mad2 being the more active species of Mad2 for Cdc20
binding. Because W75 is located in the ligand-binding site of
Mad2, Mad2
W75A does not bind to Cdc20 (Figure 2).
Mad2
L13A Forms a Symmetric C–C Mad2 Dimer
Because the Mad2
L13A,R133A double mutant exclusively
adopts the monomeric C-Mad2 conformation, we next
introduced the L13A mutation into the wild-type Mad2
(Mad2
WT) to obtain a symmetric C–C Mad2 dimer. C79 and
C106 of Mad2 are located in close proximity and tend to form
an intramolecular disulﬁde bond, causing conformational
heterogeneity. To facilitate crystallization, we created a
Mad2
L13A,C79S,C106S triple mutant, which retained its abilities
to bind to Cdc20 and inhibit APC/C in vitro (see below). For
simplicity, we will hereafter refer to this triple mutant as
Mad2
L13A. We next fractionated both Mad2
WT and Mad2
L13A
on an anion exchange column (Figure S2A). Similar to
Mad2
R133A, Mad2
WT eluted in two well-resolved peaks (Q1
and Q2), which were further fractionated on a gel ﬁltration
column. Mad2
WT in the low-salt peak (Q1) was monomeric,
whereas Mad2 in the high-salt peak (Q2) eluted on the gel
ﬁltration column with an apparent molecular mass of about
50 kDa, consistent with it being a dimer (Figure S2B). NMR
studies further conﬁrmed that the Mad2
WT monomer had the
O-Mad2 conformation, and at least one copy of Mad2 in the
dimer had the C-Mad2 conformation [17].
In contrast to Mad2
WT, Mad2
L13A eluted as a single high-
salt peak on an anion-exchange column (Figure S2A).
Mad2
L13A in this peak eluted as a dimer from a gel ﬁltration
column (Figure S2B). We next used 2D
1H-
15N transverse-
relaxation optimized heteronuclear single quantum coher-
ence spectroscopy (TROSY-HSQC) to further characterize
the conformational state of Mad2
L13A. The peaks in the
HSQC spectrum of Mad2
L13A largely overlap with those in the
HSQC spectrum of C-Mad2
R133A, indicating that Mad2
L13A
has the C-Mad2 conformation (unpublished data). The HSQC
spectrum of the 205-residue Mad2
L13A protein has only about
190 backbone peaks, consistent with each backbone amide
group of Mad2
L13A having a single peak. Thus, the column
fractionation proﬁles and the TROSY-HSQC spectrum of
Mad2
L13A suggest that Mad2
L13A forms a symmetric C–C
dimer.
We next used equilibrium sedimentation to determine the
native molecular mass of Mad2
L13A and to measure its self-
association afﬁnity (Figure S2C). After ﬁtting the data to a
single ideal species, we obtained a molecular mass of 43.5
kDa, which was about twice the predicted molecular mass of
Mad2
L13A (23.5 kDa). Fitting the data to a monomer-dimer
equilibrium model yielded a dissociation constant (Kd) of 0.25
lM for the Mad2
L13A dimer. Thus, Mad2
L13A forms a stable
symmetric dimer with relatively high afﬁnity.
Crystal Structure of the Symmetric C–C Mad2
L13A Dimer
Our extensive efforts to crystallize the Mad2
WT dimer
failed, likely due to its conformational heterogeneity. How-
ever, we obtained crystals of Mad2
L13A that diffracted X-rays
to a minimum Bragg spacing of 1.95 A ˚ and determined its
structure using molecular replacement. Data collection and
reﬁnement statistics are listed in Table 2.
Both monomers in the Mad2
L13A dimer adopt the C-Mad2
conformation and are related by noncrystallographic, two-
fold symmetry (Figures 3A–3C and S3). The two monomers
mainly interact through the C-terminal halves of their aC
helices. The high resolution of our structure of Mad2
L13A
allows clear visualization of side chains as well as several well-
ordered water molecules at the dimer interface (Figure 3D).
The dimerization interface of Mad2
L13A is symmetric and
consists of residues from the C-terminal half of aC, R184
from b89, and Q34 at the C-terminal end of aA (Figure 4).
These residues form hydrophobic interactions and extensive
networks of water-mediated hydrogen bonds. For example,
F141 forms intermolecular interactions with A137, T138,
Q134, and F141 (Figure 4A). Bridged by two tightly bound
water molecules, R133 from one monomer forms a network
of hydrogen bonds with both the backbone and side-chain
Figure 2. Ribbon Diagram of Various Mad2 Conformers
Mad2 and MBP1 are colored blue and red, respectively. The C-terminal region that undergoes a large conformational change from O-Mad2 to C-Mad2 is
colored yellow. The N- and C-termini of Mad2 are labeled. The side chains of the conformation-specific Mad2 mutants are shown as sticks. Residues for
the O-Mad2-specific mutants (F186A, T188A, H191A, and V197A) are colored green. Residues for the C-Mad2-specific mutants (L13A, W75A, L153A, and
Y156A) are colored orange. All structural figures were generated with PyMOL (http://www.pymol.org).
doi:10.1371/journal.pbio.0060050.g002
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Structure of the Symmetric Mad2 Dimercarbonyl groups of Q34 and the backbone carbonyl of T136
from the neighboring monomer (Figure 4B). The interactions
between the two Mad2 monomers observed in our structure
are consistent with previous mutagenesis results [23]. Muta-
tions of residues directly located at the dimer interface,
including R133, Q134, T140, and F141, have been shown to
disrupt Mad2 dimerization.
Residues from b89 in C-Mad2 do not form intermolecular
interactions in the C–C Mad2 dimer (Figure 4C). Residues in
b1 in O-Mad2 do not interfere with the interactions at the
dimer interface mainly involving the C-terminal end of aC.
Why does O-Mad2 not form a symmetric O–O dimer using
the same interface as that of the C–C dimer? As discussed
above, Q134 is a critical residue at the dimer interface. Its
side chain forms an intermolecular hydrogen bond with the
backbone carbonyl of T140. The orientation of the Q134 side
chain is determined by its packing with F141 from the
neighboring monomer and, more importantly, by an intra-
molecular hydrogen bond with the backbone amide of R184
(Figure 4D). In C-Mad2, R184 is located in a b bulge and forms
an electrostatic interaction with E127 on aC, thus presenting
its backbone amide for hydrogen bonding with the side chain
of Q134. In O-Mad2, R184 is located at the opposite side of
the molecule. The side chain of Q134 packs against W100 and
is not available for intermolecular hydrogen bonding. Thus,
R184 of b89 indirectly contributes to Mad2 dimerization by
forming an intramolecular hydrogen bond with the side chain
of Q134, explaining the inability of O-Mad2 to form
symmetric dimers. V197 in O-Mad2 is located in the ﬂexible
C-terminal tail, whereas it resides in b899 and packs against
W100 in C-Mad2 [17]. As a consequence, the c2 methyl group
of V197 (V197c2) has a high-ﬁeld
1H chemical shift at  0.34
parts per million (ppm) only in C-Mad2. Hence the 0.34 ppm
V197c2 peak is unique to C-Mad2. Consistent with the
essential role of R184 in symmetric C–C Mad2 dimerization,
Mad2
R184E (a point mutant of Mad2 with R184 mutated to
glutamate in wild-type Mad2) adopts the monomeric C-Mad2
conformation as evidenced by its apparent molecular weight
from the gel ﬁltration chromatography and the existence of
the unique V197c2 peak at  0.34 ppm in the 1D NMR
spectrum (Figure 4E and 4F).
Mad2
WT Forms Both Symmetric C–C and Asymmetric O–C
Dimers
Our previous biochemical and NMR studies have shown
that the Mad2
WT dimer contains at least one copy of C-Mad2
[17]. However, it is unclear whether the Mad2
WT dimer is a
symmetric C–C dimer, an asymmetric O–C dimer, or a
mixture of both. To characterize the nature of the Mad2
WT
dimer, we compared its 2D
1H-
13C HSQC spectrum with
those of the symmetric C–C Mad2
L13A dimer and an
asymmetric O–C Mad2 dimer (Figure 5). As discussed above,
the  0.34 ppm V197c2 peak is unique to C-Mad2. The
symmetric C–C and asymmetric O–C dimers each contain a
single V197c2 peak at  0.34 ppm. However, the V197c2 peak
in the C–C Mad2 dimer has a higher-ﬁeld
13C chemical shift
as compared to that in the O–C Mad2 dimer. The Mad2
WT
dimer has two peaks for V197c2, with an intensity ratio of
about 1:3 (Figure 5A). The stronger peak overlays well with
the V197c2 peak in the O–C Mad2 dimer, whereas the weaker
peak corresponds to the V197c2 peak in the C–C Mad2 dimer
(Figure 5D). Both methyl groups of I128 in the Mad2
WT dimer
also have two sets of peaks that overlay well with those of the
Table 2. Data Collection and Refinement Statistics
Data Type Parameter Value
Data collection Space group C2
Cell parameters, a, b, c (A ˚), b (8) 109.3, 191.4, 154.3, 90.02
Resolution range (A ˚) 45.37–1.95
(1.98–1.95)
Unique reflections 223,558 (10,839)
Multiplicity 2.9 (2.6)
Data completeness (%) 97.7 (95.7)
Rmerge (%)
a 6.9 (54.7)
I/r(I) 14.9 (1.6)
Wilson B-value (A ˚2) 23.3
Refinement Resolution range (A ˚) 45.00–1.95 (2.00–1.95)
No. of reflections Rwork/Rfree 220,725/2,700
Atoms (non-H protein/waters/other) 19,826/1,342/122
Rwork/Rfree (%) 21.2/24.7 (28.7/30.5)
RMSD bond length (A ˚) 0.011
RMSD bond angle (8) 1.501
Mean coordinate error (A ˚) 0.11
Mean B-value (non-H protein/waters) (A ˚2) 24.3/30.0
Correlation coefficient Fo-Fc work/free 0.955/0.937
Missing residues A: 110–112; B: 110–112; C: 110–112
D: 110–112; F: 110–113; G: 110–112
H: 110–112; I: 110–113; J: 110–113
K: 165; L: 110–112
Ramachandran analysis (favored/allowed/disallowed) (%) 98.5/1.4/0.1
Data for the outermost shell are given in parentheses.
aRmerge ¼100 RhRijIh, i— hIhij/RhRiIh,i, where the outer sum (h) is over the unique reflections and the inner sum (i) is over the set of independent observations of each unique reflection.
doi:10.1371/journal.pbio.0060050.t002
PLoS Biology | www.plosbiology.org March 2008 | Volume 6 | Issue 3 | e50 0647
Structure of the Symmetric Mad2 DimerC–C and O–C dimers (Figure 5). Thus, the Mad2
WT dimer
contains a mixture of symmetric C–C and asymmetric O–C
dimers with a molar ratio of about 1:3.
The Symmetric C–C Mad2 Dimer Is More Active in
Inhibiting APC/C
Cdc20
We next compared the APC/C
Cdc20-inhibitory activities of
Mad2
L13A, untagged dimeric Mad2
WT,a n dH i s 6-tagged
dimeric Mad2
WT using an in vitro reconstituted APC/C
ubiquitination assay (Figures 6A and S4). Addition of Mad2
to the preformed APC/C
Cdc20 complex failed to inhibit its
activity (unpublished data). Thus, to observe the APC/C
Cdc20-
inhibitory activity of Mad2, we needed to preincubate Mad2
and Cdc20 before the addition of APC/C. When Mad2 and
Cdc20 were preincubated for 2 h prior to APC/C addition,
Mad2
WT and Mad2
L13A inhibited APC/C
Cdc20 with similar
potency, with Mad2
L13A being slightly more active (Figure S4).
Both dimeric untagged and His6-tagged Mad2
WT behaved
similarly in this assay. As a control, Mad2
DC, which lost its
ability to bind to Cdc20, had no effect on the activity of APC/
C
Cdc20 (Figure S4). In contrast, when Mad2 and Cdc20 were
preincubated for only 30 min prior to their addition to APC/
C, Mad2
L13A inhibited APC/C
Cdc20 about 3-fold more potently
than did Mad2
WT (Figure 6). Therefore, at equilibrium,
Mad2
WT and Mad2
L13A are equally efﬁcient inhibitors of
APC/C
Cdc20. The fact that Mad2
L13A inhibits APC/C
Cdc20 more
efﬁciently than Mad2
WT with a shorter preincubation
suggests that Mad2
L13A has a faster on-rate in Cdc20 binding.
Because the majority of dimeric Mad2
WT forms the asym-
metric O–C dimer, whereas Mad2
L13A predominantly forms
the symmetric C–C dimer, this ﬁnding further suggests that
C-Mad2 is more active in APC/C
Cdc20 inhibition in vitro.
Overexpression of Mad2 causes mitotic arrest in human
cells [17]. We next transfected HeLa cells with a control
vector or plasmids encoding untagged Mad2
WT or Mad2
L13A.
Despite being expressed at slightly lower levels (Figure 6B),
Mad2
L13A consistently caused a higher percentage of cells to
arrest in mitosis than did Mad2
WT (Figure 6C). Therefore, as
compared to Mad2
WT, Mad2
L13A is more efﬁcient in eliciting
mitotic arrest in living cells. Mad2
L13A is thus a gain-of-
function mutant, suggesting that C-Mad2 is more active than
O-Mad2 in APC/C
Cdc20 inhibition. The ability of Mad2
L13A to
more effectively titrate p31
comet might also contribute to its
higher activity in living cells [27].
The Mad1–Mad2 Core Complex Promotes the Formation
of C-Mad2
Vink et al. [28] have recently shown that the in vitro
turnover of O-Mad2 bound to puriﬁed Mad1–Mad2 core
complex has kinetics similar to that of Mad2 turnover at
unattached kinetochores in vivo. Thus, the Mad1–Mad2 core
complex is the minimal component required for Mad2
turnover and activation at kinetochores. Furthermore,
addition of Cdc20 does not appreciably alter the rate of
Mad2 turnover on the Mad1–Mad2 core complex, suggesting
that Cdc20 binding is not required for the release of Mad2
Figure 3. Structural Overview of the Symmetric Mad2
L13A Dimer
(A–C) Ribbon diagrams of the Mad2
L13A dimer in different views. The two Mad2 molecules are named Mad2
A and Mad2
B. The secondary structural
elements located at the dimer interface are labeled. Loops not located in the electron density (residues 110–113) are shown as dashed lines. The Mad2
cores are colored green in Mad2
A and blue in Mad2
B. The N- and C-terminal regions involved in the O–C Mad2 conformational change are colored
orange in Mad2
A and yellow in Mad2
B.
(D) rA-weighted 2Fo-Fc electron density around residue F141 of Mad2
L13A contoured at the 1r level.
doi:10.1371/journal.pbio.0060050.g003
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Structure of the Symmetric Mad2 Dimerfrom the Mad1–Mad2 core complex [28]. However, the
conformational state of Mad2 released from the Mad1–
Mad2 core complex is unknown.
To address this question, we reconstituted Mad2 activation
by the Mad1–Mad2 core complex using puriﬁed recombinant
proteins in solution. We assembled the Mad1–Mad2 core
complex by mixing His6-Mad2 and the C-terminal fragment
of Mad1 (residues 495–718). As a control, we also assembled a
Mad1–Mad2 core complex that contained the His6-Ma-
d2
R133E,Q134A mutant incapable of forming O–C Mad2 dimers.
We then incubated untagged
13C-labeled O-Mad2 with the
Mad1–His6-Mad2 or Mad1–His6-Mad2
R133E,Q134A core com-
plexes at a molar ratio of 4:1 for 30 min at 37 8C. The use of
both His6-tagged and untagged Mad2 allowed us to distin-
guish, using SDS-PAGE, the Mad2 molecule in the Mad1–
Mad2 core complexes from the free O-Mad2 that turned over
on the Mad1–Mad2 core complex. The reaction mixtures
were then fractionated by gel ﬁltration chromatography at 4
8C, and the fractions were analyzed using Coomassie blue–
stained SDS-PAGE (Figures 7 and S5).
In the absence of the Mad1–Mad2 core complex, about
60% of O-Mad2 remained as monomer while 40% of Mad2
formed dimers (Figure 7A).
1H-
13C HSQC spectra conﬁrmed
that the Mad2 monomer adopted the O-Mad2 conformation
and that the Mad2 dimer contained a mixture of O–C and C–
C Mad2 dimers at a molar ratio of 3:1, as described above
(unpublished data). Thus, about 25% of O-Mad2 molecules
spontaneously converted to C-Mad2 during the course of the
experiment. In the presence of the Mad1–His6-Mad2 core
complex, about 10% of Mad2 remained bound to the Mad1–
Mad2 core complex, while virtually all free Mad2 formed
dimers (Figure 7B). Consistent with previous ﬁndings, we did
not observe substantial dissociation of His6-Mad2 from the
Mad1–Mad2 core complex. The Mad2 dimer again contained
a mixture of O–C and C–C Mad2 dimers at a 3:1 ratio based
on
1H-
13C HSQC spectra, indicating that about 60% of O-
Mad2 converted to C-Mad2 in the presence of the Mad1–
Mad2 core complex. In contrast, addition of the Mad1–His6-
Mad2
R133E,Q134A complex that lost its ability to recruit
another copy of O-Mad2 did not appreciably change the rate
of conversion from O-Mad2 to C-Mad2 (Figure 7C). Thus, the
Mad1–Mad2 core complex promotes the conversion of O-
Mad2 to C-Mad2 through O–C Mad2 dimerization. A
substantial fraction of Mad2 dissociated from the Mad1–
Mad2 core complex adopts the C-Mad2 conformation.
We note that because of the absence of Cdc20 in our assays,
unliganded C-Mad2 accumulated to high concentrations and
dimerized with a pool of O-Mad2, preventing this pool of O-
Mad2 from interacting with the Mad1–Mad2 core complex. In
cells, unliganded C-Mad2 is expected to bind to Cdc20 and is
unlikely to accumulate to high enough concentrations to
compete with the Mad1–Mad2 core complex for O-Mad2.
Nevertheless, our results indicate that in the absence of
Cdc20, O-Mad2 bound to the Mad1–Mad2 core complex can
complete the open-to-closed rearrangement and dissociate
from the Mad1–Mad2 core complex as unliganded C-Mad2.
Figure 4. Interactions at the Symmetric Mad2 Dimer Interface
(A and B) Interactions between Mad2
A and Mad2
B. The side chains of contacting residues are shown as sticks. Nitrogen and oxygen atoms are colored
blue and red, respectively. Mad2
A carbons are colored yellow; Mad2
B carbons are colored gray and labeled in italics. The tightly bound water molecules
are drawn as red spheres.
(C) Surface diagram of the Mad2
L13A dimer. Same color scheme is used as in Figure 3A–3C.
(D) Hydrogen bonds with Q134 in Mad2
A. Hydrogen bonds are indicated by red dashed lines.
(E) Mad2
R184E adopts the monomeric C-Mad2 conformation. Gel filtration chromatogram of the high-salt peak (275 mM salt, Q2) of Mad2
R184E obtained
with anion exchange chromatography is shown. Mad2
R184E has an apparent molecular mass of about 30 kDa, which is consistent with it being a
monomer. The elution profile for Mad2
R184E is shown in red, and the elution profile for molecular weight standards is shown in gray. The positions for 44
kDa and 17 kDa markers are indicated.
(F) The high-field methyl region of the 1D
1H spectrum of Mad2
R184E. The V197c2 peak ( 0.34 ppm) specific to C-Mad2 is labeled. The line width of the
methyl peaks is consistent with C-Mad2
R184E being monomeric.
doi:10.1371/journal.pbio.0060050.g004
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T h eM a d 1 – M a d 2c o r ec o m p l e xr e c r u i t sO - M a d 2a n d
converts it to C-Mad2. How is C-Mad2 released from the
Mad1–Mad2 core complex after the conversion? Mapelli et al.
[25] recently determined the crystal structure of the
asymmetric O-Mad2–C-Mad2 dimer. We thus superposed C-
Mad2 onto O-Mad2 in the O-Mad2–C-Mad2 dimer (Figure
8A). As described above, a major difference between the fold
of O-Mad2 and C-Mad2 is the translocation of the C-terminal
region from one side of the molecule to the other, forming
the b89/899 hairpin that pairs with b5i nC - M a d 2 .T o
accommodate this b hairpin and avoid steric clashes, aCi n
C-Mad2 needs to rotate slightly, which in turn causes a
rotation of the b2/3 hairpin. Consequently, in our structural
model, aC of C-Mad2 superposed with O-Mad2 develops
steric clashes with b89 and aA of the original C-Mad2
molecule in the O-Mad2–C-Mad2 dimer (Figure 8A). Thus,
C-Mad2 cannot bind to another copy of C-Mad2 using the
asymmetric O-Mad2–C-Mad2 dimerization interface. Con-
version of O-Mad2 to C-Mad2 on the Mad1–Mad2 core
complex introduces steric clashes between aC of the newly
formed C-Mad2 and parts of the C-Mad2 molecule in the
Mad1–Mad2 core complex, enabling the release of the newly
converted C-Mad2.
On the other hand, excluding the ligand-binding site, the
structures of unliganded C-Mad2 and Mad1-bound C-Mad2
are highly similar, with a backbone root mean square
deviation (RMSD) of 1.1 A ˚ . Furthermore, the ligand-binding
site and the symmetric dimerization interface of Mad2 are
located on opposite sides of the protein. Why then is C-Mad2
incapable of rebinding to the Mad1–Mad2 core using the
symmetric C-Mad2–C-Mad2 interface? A superposition of
unliganded C-Mad2 and Mad1-bound C-Mad2 reveals a
structural difference in the C-terminal end of their aC
helices (Figure 8B). Residues 135–141 in aCa d o p ta n
irregular helical conformation in unliganded C-Mad2, where-
as they adopt a 310-helical conformation in Mad1-bound C-
Mad2. Because of this important difference and a difference
in the rotamer conformation of F141, the side chain of F141
points into different directions in the two C-Mad2 structures
(Figure 8B). In unliganded C-Mad2, F141 points outward and
engages in numerous interactions at the dimerization inter-
face (see Figure 4A). In contrast, F141 in liganded C-Mad2
points inward, forms intramolecular hydrophobic interac-
tions with V181 and Y199, and is unavailable to mediate
dimerization (Figure 8B). Mutation of F141 disrupts Mad2
dimerization [23], conﬁrming the essential role of this
residue. Thus, ligand binding at one side of Mad2 might
trigger structural changes of F141 at the other side, thereby
preventing unliganded C-Mad2 from binding to liganded C-
Mad2, although we cannot rule out the possibility that the
Figure 5. Mad2
WT Forms Both Symmetric C–C and Asymmetric O–C Dimers
(A)
1H-
13C HSQC spectrum of the Mad2
WT dimer with peaks shown in black. The peaks of I128d, I128c2, and V197c2 methyl groups are boxed.
(B)
1H-
13C HSQC spectrum of the Mad2
L13A C-C dimer with peaks in blue.
(C)
1H-
13C HSQC spectrum of the Mad2
DN10 O-C dimer with peaks in red (see Materials and Methods).
(D) Overlay of the three
1H-
13C HSQC spectra described in (A–C).
doi:10.1371/journal.pbio.0060050.g005
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Structure of the Symmetric Mad2 Dimerstructural differences involving F141 are caused by crystal
packing.
Why Is Unliganded C-Mad2 More Active in APC/C
Cdc20
Inhibition?
We have shown that unliganded C-Mad2 is more active than
O-Mad2 in APC/C
Cdc20 inhibition in vitro. Because O-Mad2
and unliganded C-Mad2 form the same C-Mad2–Cdc20
complex, the difference in their APC/C
Cdc20-inhibitory activ-
ity is likely caused by different on-rates during their binding
to Cdc20. Binding of Cdc20 to O-Mad2 is a complicated
process and can be conceptually separated into four steps, not
necessarily in the stated order (Figure S6). First, b8 dissociates
from b6; the C-terminal region of Mad2 either retains the b7/8
hairpin or possibly rearranges into the b89/899 hairpin as in C-
Mad2. Second, b1 dissociates from b5, traverses through the
b5-aC loop, and forms an additional turn in aA. Third, the
Mad2-binding motif of Cdc20 forms a b strand that pairs with
b6 and extends the main b sheet of Mad2. Fourth, the b89/899
hairpin wraps around Cdc20 and translocates to pair with b5,
thus trapping Cdc20 in the closed seatbelt conformation. O-
Mad2 is thus an autoinhibited conformation in which b8
blocks the accessibility of b6 and, hence, ligand-binding
through an intramolecular interaction. Consistent with this
notion, a Mad2 deletion mutant (Mad2
1–160) that lacks b7, b8,
and the C-terminal tail still folds, exhibits cooperative
unfolding with a melting temperature of 47 8C, and retains
weak binding to MBP1 (Figure S7), possibly through the
formation of edge-on interactions between b6 and MBP1. In
contrast, Mad2
DC lacks only the C-terminal tail, but retains b7
and b8. This mutant fails to bind to MBP1 because of the
blockage of b6b yb8 (unpublished data).
We propose two nonexclusive models to explain why
unliganded C-Mad2 is more active in APC/C
Cdc20 inhibition
than O-Mad2 (Figure S6). In the ﬁrst model (pathway a),
dissociation of b1 and its subsequent traversing through the
b5-aC loop are rate-limiting steps in the conversion of O-
Mad2 to I-Mad2. These structural changes involving b1 have
already occurred in C-Mad2. The energetic barrier between
C-Mad2 and I-Mad2 may be lower than that between O-Mad2
and I-Mad2 (Figure 1). Thus, C-Mad2 can reach the I-Mad2
conformation more easily than O-Mad2, explaining why C-
Mad2 is more active in APC/C
Cdc20 inhibition. In the second
model (pathway b), because b6 is exposed in C-Mad2, but
blocked in O-Mad2, the Mad2-binding motif of Cdc20 more
readily forms an edge-on interaction with b6 of C-Mad2.
Binding of Cdc20 on one side of Mad2 allosterically triggers
the dissociation of the b89/899 hairpin from b5 on the other
side of Mad2. This hairpin then wraps around Cdc20 and
completes the binding event.
Although only C-Mad2 can form symmetric dimers, the b89/
899 hairpin of C-Mad2 does not directly participate in this
symmetric dimerization. Formation of symmetric C-Mad2–C-
Mad2 dimers does not impede the dissociation of b89/899 from
b5 and the binding of C-Mad2 to Cdc20. In contrast, the b89/
899 hairpin of C-Mad2 is a major structural element that
mediates the binding of O-Mad2. Formation of the asym-
metric O-Mad2–C-Mad2 impedes the dissociation of b89/899
from b5 and, hence, the binding of C-Mad2 to Cdc20,
explaining the dominant-negative effects of O-Mad2 on C-
Mad2. Furthermore, O-Mad2 in the O-Mad2–C-Mad2 dimer
is less active in APC/C
Cdc20 inhibition than C-Mad2, suggest-
ing that O-Mad2 cannot be activated by unliganded C-Mad2
to become I-Mad2, unlike O-Mad2 bound to the Mad1–Mad2
core complex.
Conclusion
The two-state behavior of Mad2 was discovered nearly a
decade ago [8]. It was shown that dimeric Mad2 was active in
APC/C
Cdc20 inhibition. Monomeric Mad2 not only was
inactive in APC/C
Cdc20 inhibition, but also blocked the ability
of dimeric Mad2 to inhibit APC/C
Cdc20 in a dominant-
Figure 6. The Mad2
L13A Dimer Is More Active Than the Mad2
WT Dimer in Inhibiting APC/C
Cdc20
(A) Mad2
L13A is more potent than the Mad2
WT dimer in inhibiting APC/C
Cdc20 in an in vitro reconstituted APC/C ubiquitination assay. Human Cdc20 was
incubated with Mad2
WT or Mad2
L13 dimers at varying concentrations (1–16 lM) for 30 min. The mixture was then added to APC/C immunopurified from
Xenopus egg extracts on anti-APC3 beads for another 1 h. The APC/C beads were then washed and assayed for their ubiquitin ligase activity towards
Myc-cyclin B1. The reactions mixtures were blotted with anti-Myc. The unmodified and ubiquitin-conjugated cyclin B1 proteins are indicated.
(B) Lysates of HeLa cells transfected with the indicated plasmids were blotted with the indicated antibodies.
(C) The mitotic indices of HeLa cells transfected with the indicated plasmids were quantified. At least 400 cells were counted for each transfection. The
averages and standard deviations of three separate experiments are shown.
doi:10.1371/journal.pbio.0060050.g006
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Structure of the Symmetric Mad2 Dimernegative manner. We have now determined the crystal
structure of an active dimeric Mad2 species, and show that
the active Mad2 dimer is a symmetric C-Mad2–C-Mad2 dimer.
O-Mad2 forms an asymmetric O-Mad2–C-Mad2 dimer and
blocks the ability of C-Mad2 to inhibit APC/C
Cdc20 in a
dominant-negative manner. The Mad1–Mad2 core complex
catalyzes the conversion of O-Mad2 to unliganded C-Mad2 in
the absence of Cdc20.
Our results further support the following conformational
activation model for Mad2-dependent spindle checkpoint
signaling (Figure 1). In this model, cytosolic O-Mad2 is
autoinhibited and has a high kinetic barrier for binding to
Cdc20. Upon checkpoint activation, O-Mad2 is recruited to
kinetochore-bound Mad1–Mad2 core complex through asym-
metric O-Mad2–C-Mad2 dimerization. The Mad1–Mad2 core
complex converts O-Mad2 to a short-lived intermediate Mad2
(I-Mad2). I-Mad2 is kinetically more favorable for Cdc20
binding and can bind directly to Cdc20 to form C-Mad2.
Alternatively, I-Mad2 can convert to unliganded C-Mad2 on
its own and, upon release from the Mad1–Mad2 core
Figure 7. The Mad1–Mad2 Core Complex Promotes the Conversion of O-Mad2 to C-Mad2
(A) The gel filtration chromatogram of O-Mad2 (orange line) incubated with buffer at 37 8C for 30 min. The elution profile of molecular weight standards
is shown as a dashed gray line with the native molecular mass of each standard indicated. Coomassie blue–stained SDS-PAGE of fractions with elution
volumes from 11 to 18 ml is shown in the bottom panel. The proposed interconversion scheme is shown on the right. The symbols and color scheme
are the same as in Figure 1. The same layouts are used in (B) and (C).
(B) The gel filtration chromatogram of a protein mixture containing O-Mad2 and the Mad1–Mad2 core complex (green line) incubated at 37 8C for 30
min.
(C) The gel filtration chromatogram of a protein mixture containing O-Mad2 and the Mad1–Mad2
R133E,Q134A core complex (blue line) incubated at 37 8C
for 30 min.
doi:10.1371/journal.pbio.0060050.g007
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Structure of the Symmetric Mad2 Dimercomplex, can form symmetric C-Mad2–C-Mad2 dimers. Both
monomeric C-Mad2 and symmetric C-Mad2–C-Mad2 dimer
are active in APC/C
Cdc20 inhibition.
Materials and Methods
Protein expression and puriﬁcation. The coding region of human
Mad2 was ampliﬁed by polymerase chain reaction (PCR) and cloned
into either a pGEX-KT or pQE30 (Qiagen) vector, each of which
also included a tobacco etch virus (TEV) protease cleavage site. Mad2
mutants were generated with the QuikChange mutagenesis kit
(Stratagene). The pQE30-Mad2 plasmids were transformed into
the bacteria strain M15[pREP4] to produce various His6-tagged
Mad2 proteins. These proteins were puriﬁed with Ni
2þ-NTA agarose
resin (Qiagen) and cleaved with TEV protease to remove the His6-tag.
The proteins were further puriﬁed by anion exchange chromatog-
raphy followed by gel ﬁltration chromatography. Expression of pGEX-
Mad2
L13A,C79S,C106S (referred to as Mad2
L13A for simplicity) in the
bacterial strain BL21 produced a GST-Mad2 fusion protein. The
fusion protein was isolated with glutathione-Sepharose beads (GE
Healthcare) and cleaved with TEV protease to remove GST. The
Mad2
L13A protein was further puriﬁed by anion exchange and gel
ﬁltration chromatography. The puriﬁed Mad2
L13A dimer was
concentrated to 3 mg/ml in a buffer containing 20 mM Tris (pH
8.0), 50 mM NaCl, and 2 mM TCEP.
To prepare the asymmetric Mad2
DN10 O–C dimer, we ﬁrst
expressed and puriﬁed the His6-Mad2
DN10 monomer in the O-Mad2
conformation. We had previously shown that O-Mad2 was stable at 4
8C, whereas it underwent slow spontaneous conversion to C-Mad2 at
30 8C [17]. Incubation of O-Mad2
DN10 with TEV overnight at 4 8C did
not result in the cleavage of the His6-tag from His6-O-Mad2
DN10,
whereas TEV efﬁciently cleaved other unrelated His6-tag proteins
under the same conditions. This result suggested that the TEV
cleavage site in His6-O-Mad2
DN10 was not accessible. We thus
incubated the mixture of His6-O-Mad2
DN10 and TEV overnight at
30 8C, which resulted in the cleavage of about 50% of the His6-O-
Mad2
DN10 molecules. This mixture of His6-tagged and untagged
Mad2
DN10 fractionated as a single high-salt peak on an anion
exchange column and as a 1:1 heterodimer on a gel ﬁltration column.
Moreover, the
1H-
13C HSQC spectrum of the Mad2
DN10 dimer was
virtually identical to that of O-Mad2
DC–C-Mad2
WT dimer, indicating
that Mad2
DN10 indeed formed an O-Mad2–C-Mad2 dimer. We
reasoned that as His6-O-Mad2
DN10 spontaneously converted to His6-
C-Mad2
DN10 or an intermediate Mad2 state, its TEV cleavage site
became accessible, resulting in the cleavage of the His6-tag in this
population of Mad2
DN10. The formation of the His6-O-Mad2
DN10–
untagged C-Mad2
DN10 dimer prevented the further conversion of
His6-O-Mad2
DN10 to His6-C-Mad2
DN10, and thus prevented further
cleavage of the His6-tag in the rest of the Mad2
DN10 molecules by TEV.
Crystallization, data collection, and structure determination. The
Mad2
L13A dimer was crystallized at 20 8C using the sitting-drop
vapor-diffusion method. Drops were formed by mixing 1 ll of protein
and 1 ll of reservoir solution that contained 19% (w/v) PEG 2000,
16% (v/v) glycerol, 100 mM Tris (pH 8.0), and 0.3 M MgCl2. Larger
crystals were obtained by seeding using the same conditions. The
crystals were cryoprotected with reservoir solution and then ﬂash-
cooled in liquid propane. Crystals diffracted to a minimum Bragg
spacing (dmin) of about 1.9 A ˚ . At lower resolution, the diffraction data
are compatible with an orthorhombic crystal symmetry. However, at
higher resolution, the crystals exhibited the symmetry of space group
C2 with cell dimensions of a ¼ 109 A ˚ , b ¼ 191 A ˚ , c ¼ 154 A ˚ and b ¼
90.028 with 12 molecules per asymmetric unit.
Diffraction data were collected at beamline 19-ID (SBC-CAT) at
the Advanced Photon Source (Argonne National Laboratory,
Argonne, Illinois, United States) and processed with HKL2000 [29].
The Mad2
L13A dimer structure was determined by the molecular
replacement method with the program Phaser [30] using the Mad2
core (residues 12–36, 58–158, and 177–205) from the structure of
Mad2–MBP1 as the search model. Reﬁnement was performed with
REFMAC5 [31] from the CCP4 package [32] using diffraction data to a
resolution of 1.95 A ˚ , interspersed with manual rebuilding using the
program Coot [33]. The 12 molecules in the asymmetric unit are
arranged in two sets of six molecules related by almost perfect
Figure 8. Release of C-Mad2 from the Mad1–Mad2 Core Complex
(A) Superposition of C-Mad2 with O-Mad2 in the O–C Mad2 dimer. MBP1-bound C-Mad2 is colored in cyan except for its C-terminal region, which is
colored yellow. O-Mad2 in the O–C Mad2 dimer is in magenta. The unliganded C-Mad2 monomer from the Mad2
L13A dimer is colored green with its C-
terminal region in orange. The steric clashes between C-Mad2 and MBP1-bound Mad2 in this model are indicated by red arrows.
(B) Superposition of unliganded C-Mad2 and the Mad1-bound C-Mad2 (top panel). The unliganded C-Mad2 monomer from the Mad2
L13A dimer is
shown in green. Mad1-Bound C-Mad2 is in cyan with its aC helix colored gray. The side chains of F141, V181, and Y199 in Mad1-bound C-Mad2 are
shown as sticks and colored gray while the side chain of F141 of unliganded Mad2 is colored green. The C-terminal ends of the aC helices are boxed
with red dashed lines. The bottom panel shows the stereo view of the superposed backbones of residues 135–141 at the C-terminal ends of the aC
helices in the two Mad2 molecules. The side chains of F141 in both molecules are shown with the same color schemes as described above.
doi:10.1371/journal.pbio.0060050.g008
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Structure of the Symmetric Mad2 Dimertranslational symmetry. No noncrystallographic symmetry restraints
were used during reﬁnement. Between one and four residues per
Mad2 molecule were disordered and were not included in the model.
The ﬁnal model (Rwork ¼ 21.2% and Rfree ¼ 24.7%) contains 2,464
residues, 1,342 water molecules, eight magnesium ions, 32 chloride
ions, as well as ten short PEG molecules. All but two residues are in
the favored region of the Ramachandran plot. The two residues in the
disallowed region are located at surface loops and are associated with
weak electron density. Data collection and structure reﬁnement
statistics are summarized in Table 2.
Analytical ultracentrifugation and isothermal titration calorimetry.
Sedimentation equilibrium experiments were performed at 4 8C with
a Beckman Optima XL-I analytical ultracentrifuge using a four-
position An60Ti rotor with six-channel equilibrium centerpieces
(optical path length ¼ 1.2 cm) and an absorbance optical detection
system (Beckman Instruments). Sample channels were ﬁlled with 100
ll of protein at three different concentrations (0.23, 0.36, and 0.50
mg/ml) in a buffer containing 20 mM Tris (pH 8.0), 50 mM NaCl, 0.2
mM TCEP. The reference channels were ﬁlled with 110 ll of buffer.
The absorbance at 280 nm was monitored for each cell in 0.002-cm
steps. Samples were centrifuged at 13,000 rpm, 17,500 rpm, and
25,000 rpm until equilibrium had been reached, followed by
overspeed runs at 42,000 rpm to obtain baseline values of absorbance.
The partial speciﬁc volume (0.7451 ml/g) and the solvent density
(1.0054 g/ml) were calculated using the program SEDNTERP (http://
rd.plos.org/pbio.0060050). Sedimentation equilibrium datasets were
ﬁtted to the self-association model using Beckman Optima XL-A/Xl-I
data analysis software (Origin 6.03). A global analysis was carried out
for datasets obtained at different concentrations and rotor speeds.
Isothermal titration calorimetry was performed as described [27].
NMR spectroscopy. ll NMR spectra were acquired at 30 8Co na
Varian Unity Inova 800 MHz spectrometer using H2O/D2O 95:5 (v/v)
as the solvent. Samples typically contained 0.1 mM protein in a buffer
consisting of 50 mM phosphate (pH 6.8), 300 mM KCl, and 1 mM DTT.
Mammalian tissue culture, transfection, and APC/C assays. HeLa
Tet-on (Invitrogen) cells were cultured in DMEM medium supple-
mented with 10% fetal bovine serum. The cells were transfected with
pCS2-Mad2 vectors using Effectene (Qiagen). After 36 h, the cells
were stained with Hoechst 33342 (Molecular Probes) and examined
using an inverted ﬂuorescence microscope (Zeiss). Lysates of the
transfected cells were blotted using the appropriate antibodies. APC/
C assays were performed as described [34,35].
Supporting Information
Figure S1. Electrostatic Potential Surfaces of O-Mad2 and C-Mad2
Surface representations for O-Mad2 and C-Mad2 in similar orienta-
tions. Positive and negative electrostatic potentials are colored blue
and red, respectively. The negatively charged patch around b6i nC -
Mad2 is circled.
Found at doi:10.1371/journal.pbio.0060050.sg001 (2.6 MB TIF).
Figure S2. Dimerization Properties of Mad2
WT and Mad2
L13A
(A) Anion exchange chromatograms of Mad2
WT (top panel) and
Mad2
L13A (bottom panel). The salt concentrations in which each
sample eluted are indicated. The Coomassie blue-stained SDS-PAGE
of column fractions are shown below the corresponding chromato-
gram.
(B) Gel ﬁltration chromatograms of Mad2
WT in the Q1 peak (top
panel) as described in (A), Mad2
WT in the Q2 peak (middle panel),
and Mad2
L13A (bottom panel). The elution proﬁle of molecular
weight standards is shown as a dashed gray line with the native
molecular mass of each standard indicated.
(C) Equilibrium sedimentation analysis of Mad2
L13A. Datasets were
collected at centrifugation speeds of 13,000 rpm (black), 17,500 rpm
(red), and 25,000 rpm (green). The plots of the best ﬁts (bottom panel)
and their residuals (top panel) were generated by ﬁtting the data to a
monomer-dimer equilibrium model. The triangles and squares
denote samples at 0.36 mg/ml and 0.50 mg/ml concentrations,
respectively.
Found at doi:10.1371/journal.pbio.0060050.sg002 (5 MB TIF).
Figure S3. Two Types of Interfaces between Mad2
L13A Protomers
The asymmetric unit of the Mad2
L13A crystals contains 12 monomers.
The pairwise backbone root mean square deviations (RMSD) for the
12 monomers are below 0.5 A ˚ . A group of four Mad2 protomers
(named Mad2
A, Mad2
B, Mad2
C, and Mad2
D) is shown in ribbon
representations to display the two types of molecular interfaces
observedintheMad2
L13Astructure.Thecolorcodeisasfollows:Mad2
A
isgreen,Mad2
Bisblue,Mad2
Cismagenta,andMad2
Disorange.Mad2
A
and Mad2
B, as well as Mad2
C and Mad2
D, are related by a noncrystallo-
graphictwo-foldaxis.Inoneinterface,Mad2
AandMad2
Binteractwith
each other mainly through the C-terminal halves of the aC helices. In
theotherinterface,theN-terminalregions ofMad2
CandMad2
Dinsert
into the ligand-binding pockets of Mad2
A and Mad2
B, respectively.
This tetrameric arrangement likely does not reﬂect the oligomeric
status of Mad2
L13A, as it exists predominantly as a dimer in solution,
based on gel ﬁltration and equilibrium sedimentation experiments
(Figure S2). Furthermore, mutations of several residues on aC,
including R133A, completely disrupt Mad2 dimerization in solution,
indicating that aC is the major structural determinant for Mad2
dimerization. Finally, the N-terminal region of Mad2 does not share
sequence homology with the Mad2-binding consensus motifs and is
dispensable for dimer formation. Therefore, the interactions between
the N-terminal regions of Mad2
C,D and the ligand-binding sites of
Mad2
A,B are very likely a result of crystal packing. Though these types
of interactions are unlikely to be functionally relevant, they may
explain the ability of Mad2 dimers to form higher-order oligomers at
high concentrations.
Found at doi:10.1371/journal.pbio.0060050.sg003 (3.8 MB TIF).
Figure S4. Both Mad2
WT and Mad2
L13A Dimers Inhibit APC/C
Efﬁciently with Longer Preincubation of Cdc20 and Mad2
Human Cdc20 was incubated with Mad2
WT or Mad2
L13A dimers at
varying concentrations (1–16 lM) for 2 h. The mixture was then
added to APC/C immunopuriﬁed from Xenopus egg extracts on anti-
APC3 beads for another 1 h. The APC/C beads were then washed and
assayed for their ubiquitin ligase activity towards Myc-cyclin B1. The
reactions mixtures were blotted with anti-Myc. The unmodiﬁed and
ubiquitin-conjugated cyclin B1 proteins are indicated.
Found at doi:10.1371/journal.pbio.0060050.sg004 (1.4 MB TIF).
Figure S5. The Mad1–Mad2 Core Complex Promotes the Conversion
of O-Mad2 to C-Mad2
Overlay of the gel ﬁltration chromatograms shown in Figure 7. ‘‘Core
þ O-Mad2’’ (green): the protein mixture containing O-Mad2 and the
Mad1–Mad2 core complex incubated at 37 8C for 30 min; ‘‘Core
control þ O-Mad2’’ (blue): the protein mixture containing O-Mad2
and the Mad1–Mad2
R133E,Q134A core complex incubated at 37 8C for
30 min; ‘‘Buffer þ O-Mad2’’ (orange): O-Mad2 incubated with buffer
at 37 8C for 30 min; ‘‘Standards’’ (gray): molecular weight standards
are shown with a dashed gray line with the native molecular mass of
each standard indicated; and ‘‘Core’’ (red): the Mad1–Mad2 core
complex alone.
Found at doi:10.1371/journal.pbio.0060050.sg005 (3 MB TIF).
Figure S6. Proposed Mechanisms for the Binding of Cdc20 to O-
Mad2 or Unliganded C-Mad2
Topology diagrams that illustrate the structural changes in different
Mad2 species and the proposed pathways for their binding to Cdc20
are shown. The secondary structural elements are labeled. The core
domain for Mad2 is colored blue. The N- and C-terminal regions
involved in the Mad2 conformational change are colored yellow,
except for residues 172–175 and 184–192, which are shown in green.
Cdc20 is shown in red.
Found at doi:10.1371/journal.pbio.0060050.sg006 (694 kB TIF).
Figure S7. Mad2
1–160 Undergoes Cooperative Unfolding and Retains
Binding to MBP1
(A) The temperature-induced denaturation curves of Mad2
DN10
(shown as solid triangles) and Mad2
1–160 (solid squares) as monitored
by the intensity of the circular dichroism (CD) signal at 220 nm.
(B) Overlay of
1H-
15N HSQC spectra of free Mad2
1–160 (black) and
Mad2
1–160 in complex with MBP1 (red). The peaks in the Mad2
1–160
spectra are well dispersed, indicating that Mad2
1–160 is folded. Several
peaks undergo signiﬁcant chemical shift changes upon the addition
of MBP1, indicating that Mad2
1–160 binds to MBP1.
Found at doi:10.1371/journal.pbio.0060050.sg007 (1.9 MB TIF).
Accession Numbers
The atomic coordinates and structure factors for the symmetric C–C
Mad2
L13A dimer have been deposited in the Protein Data Bank (http://
www.rcsb.org/pdb/home/home.do) with accession number PDB ID
2VFX. The Protein Data Bank accession numbers for other proteins
discussed in this paper are as follows: Mad1-bound C-Mad2 (PDB ID
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Structure of the Symmetric Mad2 Dimer1GO4), Mad2–MBP1 (PDB ID 1KLQ), and O–C Mad2 dimer (PDB ID
2V64).
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